Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Visual Cleanliness Test Development – V 2.0

Posted on By

Analytical Method Development: SOP for Visual Cleanliness Test Development – V 2.0

Standard Operating Procedure for Development of Visual Cleanliness Testing Method for Equipment Surfaces


Department Analytical Method Development
SOP No. SOP/AMD/237/2025
Supersedes SOP/AMD/237/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the procedure for developing a visual inspection method to confirm the absence of visible residues on pharmaceutical manufacturing equipment surfaces following cleaning operations, as part of the

cleaning validation program.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) department for establishing standardized visual cleanliness acceptance criteria and method validation in pharmaceutical production facilities.

3. Responsibilities

  • Analytical Scientist: Designs and validates visual inspection methods under standardized lighting and surface conditions.
  • QC Analyst: Performs mock visual testing to assess sensitivity and repeatability.
  • QA Executive: Reviews validation documentation and approves the method for routine GMP use.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that the visual inspection method is appropriately validated and that visual criteria are consistently applied during cleaning validation and verification activities.

See also  Analytical Method Development: HPLC Dissolution Profile Method Development - V 2.0

5. Procedure

5.1 Preparation of Visual Standards

  1. Prepare surfaces (e.g., stainless steel coupons) by spiking known quantities of API/excipient solutions and allowing them to dry completely.
  2. Prepare reference surfaces with known concentrations of residue (e.g., 1 µg/cm², 10 µg/cm²).
  3. Assign numerical or coded reference values to each visual standard.

5.2 Visual Inspection Environment

  1. Ensure the inspection area has lighting of at least 300 lux.
  2. Use white light (4000–5000 K) and standardized viewing angles (30–45° from the surface).
  3. Ensure no reflective glare or shadows obstruct the inspection area.

5.3 Training of Inspectors

  1. Train personnel in identifying residues and distinguishing them from surface discoloration, scratches, or stains.
  2. Use visual standard panels for sensitivity assessment.
  3. Only qualified personnel (visual inspectors) are authorized to conduct visual inspections.

5.4 Inspection Process

  1. Post-cleaning, inspect equipment surfaces visually under defined lighting conditions.
  2. Observe for any discoloration, spots, residue streaks, or particulate matter.
  3. Document observations in the visual inspection log (Annexure-1).
See also  Analytical Method Development: HPLC Gradient Method Development - V 2.0

5.5 Validation of Visual Inspection Method

  1. Perform limit of detection testing using panels spiked with known residue amounts.
  2. Acceptance criteria:
    • Lowest amount visually detected by 90% of trained personnel = Visual Detection Limit (VDL)
    • VDL must be below the calculated MACO equivalent per surface area

5.6 Acceptance Criteria

  1. No visible residue, stains, discoloration, or contamination under specified conditions.
  2. All cleaning must meet both analytical (e.g., swab/rinse) and visual acceptance limits.

5.7 Documentation

  1. Maintain training logs, VDL results, validation summary report, and visual inspection log.
  2. Cross-reference with cleaning batch records and analytical results.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • MACO: Maximum Allowable Carryover
  • VDL: Visual Detection Limit
  • GMP: Good Manufacturing Practice

7. Documents

  1. Visual Inspection Log – Annexure-1
  2. Visual Detection Training Sheet – Annexure-2
  3. Visual Method Validation Report – Annexure-3

8. References

  • ICH Q7: GMP for Active Pharmaceutical Ingredients
  • FDA Guidance: Guide to Inspections – Validation of Cleaning Processes
  • ISPE Cleaning Validation Guide
See also  Analytical Method Development: Titrimetric Assay Development for Acidity - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Kiran Bhatt Alok Sinha Sunita Reddy
Designation Validation Officer QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Visual Inspection Log

Date Equipment Surface Area Observation Inspector Status
20/05/2025 Blender Inner Wall No visible residue Rajesh Kumar Pass

Annexure-2: Visual Detection Training Sheet

Inspector Name Panel No. Residue Level (µg/cm²) Detected? Remarks
Neha Agarwal VS-2 10 Yes Clearly visible

Annexure-3: Visual Method Validation Report

Visual cleanliness inspection method validated using standard reference panels spiked with Metronidazole API. VDL confirmed at 5 µg/cm² with 93% detection accuracy by trained staff. Method suitable for cleaning validation visual inspection program.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included detection limit protocol and lighting standardization Annual Review and GMP Enhancement Sunita Reddy
10/04/2022 1.0 Initial SOP Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Routine Maintenance and Cleaning of Packing Machines – V 2.0
Next Post: Gel Manufacturing: SOP for Operation of Gel Transfer Pump – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version